Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Marbella
Clinical trial register · Spain

Clinical Trials in Marbella, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Loxo Oncology, Inc.3 Novartis Pharmaceuticals3 Merck Sharp & Dohme LLC3 Samyang Biopharmaceuticals Corporation2 Hoffmann-La Roche2
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Marbella

49 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Fundacion SEIMC-GESIDA
Not applicable
1,324
Marbella
2026-10-31
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Marbella, A Coruña, Barcelona, Boadilla del Monte, Cáceres, Córdoba, El Palmar, Granada
2026-10-26
Recruiting
Hoffmann-La Roche
Phase 3
380
Marbella, Pamplona, Barcelona, Madrid, Salamanca
2026-06-23
Recruiting
Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC)
NCT07627399Stroke, Acute Stroke, Ischemic Stroke, Hemorrhagic Stroke
University of Malaga
Not applicable
700
Antequera, Marbella, Ronda, Málaga
2026-05-12
Recruiting
Regeneron Pharmaceuticals
Phase 2
99
Barcelona, Marbella, Madrid, Salamanca, Toledo
2026-05-06
Recruiting
Eli Lilly and Company
Phase 2
531
Barcelona, Centelles, Granada, Madrid, Marbella, Salamanca, Santiago de Compostela
2026-05-06
Recruiting
Eli Lilly and Company
Phase 2
342
Barcelona, Centelles, Granada, Madrid, Marbella, Salamanca, Santiago de Compostela
2026-04-29
Recruiting
Study of RRS® HA Long Lasting for Improving Facial Wrinkles and Skin Quality
NCT07551609Photoaged Facial Skin, Photoaging, Wrinkle Reduction, Skin Quality Improvement
Skin Tech Pharma Group S.L.U.
Not applicable
207
Barcelona, Madrid, Marbella
2026-04-26
Recruiting
Inhibikase Therapeutics
Phase 3
486
Málaga, Barcelona, Santander, Madrid, Marbella, Seville, Toledo, Valencia
2026-04-23
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
DrugTNX-103
Tenax Therapeutics, Inc.
Phase 3
540
Barcelona, Lugo, Madrid, Marbella, Málaga, Pamplona, Salamanca, Seville
2026-03-03
Recruiting
Samyang Biopharmaceuticals Corporation
Not applicable
30
Marbella
2026-03-02
Recruiting
Takeda
Phase 3
183
Madrid, Marbella, Palma de Mallorca, Salamanca, Valencia
2026-01-14
Recruiting
Samyang Biopharmaceuticals Corporation
Not applicable
30
Marbella
2025-11-24
Recruiting
Regeneron Pharmaceuticals
Phase 3
2,000
Vitoria-Gasteiz, Marbella, Pamplona, Barcelona, Madrid, Valencia
2025-11-24
Recruiting
Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
NCT07168434IBS (Irritable Bowel Syndrome), IBS-D (Diarrhea-predominant), IBS, Mixed Symptoms
DrugSaccharomyces Boulardii
Biocodex
Phase 3
406
Barcelona, León, Madrid, Marbella, Málaga, Oviedo
2025-10-22
Not yet open
Hospital Costa del Sol
Not applicable
90
Marbella, Santa Cruz de Tenerife
2025-10-01
Recruiting
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
50
Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, El Palmar, Marbella, Pamplona, Salamanca
2025-09-30
Recruiting
Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
NCT06963203Graves Disease, Amiodarone-Induced Thyrotoxicosis, Thyroidectomy
Andrea Goldmann
Observational
486
Granada, Marbella
2025-07-01
Recruiting
GlaxoSmithKline
Phase 3
981
Pozuelo de Alarcón, Marbella, Alzira, Barcelona, Benalmádena, Ferrol, GaldakaoVizcaya, Madrid
2025-06-20
Active, closed
Novartis Pharmaceuticals
Observational
219
Cadiz, Granada, Huelva, Jaén, Marbella, Mallorca, Puerto Real, Santander
2025-06-16
Recruiting
BeOne Medicines
Phase 3
630
Barcelona, LHospitalet de Llobregat, Madrid, Marbella, Salamanca, Santander, Seville
2025-06-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
440
Marbella, Barcelona, Madrid, Seville, Toledo
2025-04-16
Recruiting
AbbVie
Observational
700
A Coruña, Badalona, Sabadell, Córdoba, Marbella, Pamplona, Seville, Manises
2025-03-28
Recruiting
Summit Therapeutics
Phase 3
780
Barakaldo, Santander, Badajoz, Las Palmas, Madrid, Sevilla, Marbella, Seville
2025-02-27
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Barcelona, L'Hospitalet Del Llobregat, Madrid, Majadahonda, Marbella, Oviedo, Salamanca, Santander
2025-01-03
Recruiting
OSE Immunotherapeutics
Phase 3
363
Palma de Mallorca, Badalona, L'Hospitalet de Llobregat, Barakaldo, A Coruña, Las Palmas de Gran Canaria, Majadahonda, Marbella
2024-12-03
Active, closed
Genmab
Phase 3
191
L'Hospitalet de Llobregat, Córdoba, Santiago de Compostela, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Marbella, Pamplona, Alicante
2024-11-25
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Santander, Marbella, Madrid, Toledo
2024-10-29
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Santiago Compostela, Marbella, Toledo, Barcelona, Las Palmas de Gran C, Seville
2024-10-24
Active, closed
Merus B.V.
Phase 3
699
Badalona, Barcelona, Madrid, Marbella, Pamplona, Valencia
2024-09-25
Recruiting
PETHEMA Foundation
Phase 2
106
Alicante, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Marbella, Málaga, Oviedo
2024-09-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Badalona, L'Hospitalet de Llobregat, Santander, Barcelona, Madrid, Marbella, Salamanca
2024-07-16
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Albacete, Barcelona, Las Palmas de Gran Canaria, Lleida, Madrid, Marbella, Oviedo, Salamanca
2024-06-07
Recruiting
GELLC (Grupo Español de Leucemia Linfocítica Crónica)
Phase 2
34
Barcelona, L'Hospitalet de Llobregat, Santander, Las Palmas de Gran Canaria, Madrid, Murcia, Marbella, Oviedo
2024-05-15
Active, closed
ViiV Healthcare
Phase 3
307
Badalona, Barcelona, Elche Alicante, La Laguna-Tenerife, Madrid, Marbella, Palma de Mallorca, Valencia
2024-02-21
Active, closed
International Non-selection Study for ERA® Test in Patients With Previous Implantation Failures
NCT06097559Infertility of Uterine Origin, Implantation Failure
Igenomix
Observational
738
Madrid, Marbella, Málaga, Seville, Valladolid
2024-01-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Badalona, L'Hospitalet Del Llobregat, Barcelona, Santiago de Compostela, Madrid, Marbella, Albacete, Málaga
2023-12-31
Recruiting
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
NCT05999877Chronic Lymphocytic Leukemia
AstraZeneca
Observational
315
Almería, Córdoba, Granada, Jaén, Marbella, Málaga, Seville, Zaragoza
2023-07-11
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Ferrol, Santiago, Santiago Compostela, Elche, Granada, Huelva, Marbella, Málaga
2023-03-09
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Palma de Mallorca, Granollers, L'Hospitalet de Llobregat, Ferrol, Santiago de Compostela, Logroño, Las Palmas de Gran Canaria, Marbella
2022-11-21
Recruiting
Celgene
Phase 3
810
Palma, Barcelona, Murcia, Marbella, Cáceres, León, Madrid
2022-09-20
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Barcelona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Marbella, Pamplona, Santander, Seville
2022-07-22
By invitation
AstraZeneca
Phase 3
214
Barcelona, Girona, Madrid, Marbella, Santiago de Compostela, Valencia
2022-04-19
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Barcelona, Sabadell, Sant Pere de Ribes, Terrassa, Marbella, Valladolid, Madrid
2021-11-22
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Barcelona, Madrid, Majadahonda, Marbella, Oviedo, Pozuelo de Alarcón, Seville, Toledo
2021-09-20
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
L'Hospitalet de Llobregat, Cáceres, Pozuelo de Alarcón, Marbella, Pamplona, Barcelona, Madrid, Pozuelo de Alarcon (madrid)
2020-08-20
Active, closed
Epizyme, Inc.
Phase 3
599
Barcelona, Marbella, El Palmar, Madrid, Pamplona, Salamanca, Seville
2020-06-11
Active, closed
AbbVie
Phase 3
265
Palma de Mallorca, Marbella, Ourense, San Cristóbal de La Laguna, Barcelona, Girona, León, Madrid
2018-10-22
Active, closed
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
50
Barcelona, Terrassa, Burgos, Alcorcón, Madrid, Cartagena, Marbella, Seville
2016-05-18
Rows per page Showing 1–49 of 49
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/marbella

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 49 of those studies with a site in Marbella.

How many clinical trials are recruiting in Marbella?

28 of the 49 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 17 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Marbella), 49 studies
PhaseStudiesRecruitingShare
Phase 3251251%
Phase 210720.4%
Not applicable7514.3%
Observational6312.2%
Phase 1/2112%

Most active sponsors

Lead sponsors with the most studies (Marbella)
Lead sponsorStudiesRecruiting
Loxo Oncology, Inc.32
Merck Sharp & Dohme LLC30
Novartis Pharmaceuticals31
AbbVie21
AstraZeneca21
Eli Lilly and Company22
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea21
Hoffmann-La Roche21
Regeneron Pharmaceuticals22
Samyang Biopharmaceuticals Corporation22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.